Second quarter 2022 results

Second quarter 2022 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

(14:30 - 16:00 CET / 8:30am – 10am EST)


Paul Hudson

Chief Executive Officer

Jean-Baptiste de Chatillon

Chief Financial Officer

Bill Sibold

Specialty Care

Olivier Charmeil

General Medicines

John Reed


Thomas Triomphe


Julie Van Ongevalle

Consumer Healthcare

Roy Papatheodorou

General Counsel


Our performance in the second quarter was once again fueled by both higher sales across our key growth drivers and outstanding financial results. We remain ahead of schedule on our strategy and are confident in the outlook for the second half of the year.

Paul Hudson

Chief Executive Officer, Sanofi


Press release


Q2 2022 Income statements

Q3 2022 net sales by GBU, franchise, geographic region and product

R&D appendix

Download infographic

Q2 2022 Memorandum for modelling purposes


Investor Relations
investor.relations (at) 

More contact information